
Oluwatosin A. Ogunbiyi
Examiner (ID: 9383, Phone: (571)272-9939 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645 |
| Total Applications | 1113 |
| Issued Applications | 596 |
| Pending Applications | 141 |
| Abandoned Applications | 402 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18754010
[patent_doc_number] => 20230357373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => METHODS AND COMPOSITIONS FOR EVALUATING AND TREATING FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 17/786449
[patent_app_country] => US
[patent_app_date] => 2020-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18352
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17786449
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/786449 | METHODS AND COMPOSITIONS FOR EVALUATING AND TREATING FIBROSIS | Dec 15, 2020 | Pending |
Array
(
[id] => 20466618
[patent_doc_number] => 12522651
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-13
[patent_title] => BCG car constructs and methods of their manufacture and use
[patent_app_type] => utility
[patent_app_number] => 17/782818
[patent_app_country] => US
[patent_app_date] => 2020-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10164
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 226
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17782818
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/782818 | BCG car constructs and methods of their manufacture and use | Dec 7, 2020 | Issued |
Array
(
[id] => 17243455
[patent_doc_number] => 20210363198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => PEPTIDE COMPOSITION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/113793
[patent_app_country] => US
[patent_app_date] => 2020-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13022
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17113793
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/113793 | PEPTIDE COMPOSITION AND USES THEREOF | Dec 6, 2020 | Abandoned |
Array
(
[id] => 18443602
[patent_doc_number] => 11679153
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-20
[patent_title] => Methods for inducing an immune response
[patent_app_type] => utility
[patent_app_number] => 17/105769
[patent_app_country] => US
[patent_app_date] => 2020-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13356
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17105769
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/105769 | Methods for inducing an immune response | Nov 26, 2020 | Issued |
Array
(
[id] => 17148392
[patent_doc_number] => 11141444
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-12
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 17/102243
[patent_app_country] => US
[patent_app_date] => 2020-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 24
[patent_no_of_words] => 11066
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17102243
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/102243 | None | Nov 22, 2020 | Issued |
Array
(
[id] => 16901156
[patent_doc_number] => 20210180072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => GENETICALLY MODIFIED BACTERIA STABLY EXPRESSING IL-10 AND INSULIN
[patent_app_type] => utility
[patent_app_number] => 17/092624
[patent_app_country] => US
[patent_app_date] => 2020-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30811
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17092624
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/092624 | Genetically modified bacteria stably expressing IL-10 and insulin | Nov 8, 2020 | Issued |
Array
(
[id] => 18056440
[patent_doc_number] => 20220387526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => UREMIC TOXIN REDUCING AGENT
[patent_app_type] => utility
[patent_app_number] => 17/769904
[patent_app_country] => US
[patent_app_date] => 2020-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8660
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17769904
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/769904 | UREMIC TOXIN REDUCING AGENT | Oct 19, 2020 | Abandoned |
Array
(
[id] => 18581625
[patent_doc_number] => 20230263877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => NOVEL VACCINE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/769130
[patent_app_country] => US
[patent_app_date] => 2020-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20368
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17769130
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/769130 | NOVEL VACCINE COMPOSITIONS | Oct 14, 2020 | Abandoned |
Array
(
[id] => 16990230
[patent_doc_number] => 20210228650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 17/067544
[patent_app_country] => US
[patent_app_date] => 2020-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13997
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17067544
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/067544 | COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS | Oct 8, 2020 | Abandoned |
Array
(
[id] => 18784815
[patent_doc_number] => 20230372461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => IMMUNOGENIC PEPTIDES, COMPOSITIONS, AND METHODS FOR THE TREATMENT AND/OR PREVENTION OF MALARIA
[patent_app_type] => utility
[patent_app_number] => 17/767476
[patent_app_country] => US
[patent_app_date] => 2020-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12682
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -62
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17767476
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/767476 | IMMUNOGENIC PEPTIDES, COMPOSITIONS, AND METHODS FOR THE TREATMENT AND/OR PREVENTION OF MALARIA | Oct 8, 2020 | Pending |
Array
(
[id] => 18006318
[patent_doc_number] => 20220365084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => IMMUNOCHROMATOGRAPHIC DEVICE FOR EXTRACTING AND MEASURING SUGAR CHAIN ANTIGEN
[patent_app_type] => utility
[patent_app_number] => 17/766106
[patent_app_country] => US
[patent_app_date] => 2020-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12591
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 258
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17766106
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/766106 | Immunochromatographic device for extracting and measuring sugar chain antigen | Oct 1, 2020 | Issued |
Array
(
[id] => 16581512
[patent_doc_number] => 20210015914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => METHODS AND COMPOSITIONS RELATED TO ACCELERATED HUMORAL AFFINITY
[patent_app_type] => utility
[patent_app_number] => 17/038423
[patent_app_country] => US
[patent_app_date] => 2020-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8386
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17038423
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/038423 | METHODS AND COMPOSITIONS RELATED TO ACCELERATED HUMORAL AFFINITY | Sep 29, 2020 | Abandoned |
Array
(
[id] => 16583110
[patent_doc_number] => 20210017512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => CELL-TARGETING MOLECULES COMPRISING PROTEASE-CLEAVAGE RESISTANT, SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES AND CARBOXY-TERMINAL MOIETIES
[patent_app_type] => utility
[patent_app_number] => 17/030657
[patent_app_country] => US
[patent_app_date] => 2020-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67724
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17030657
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/030657 | CELL-TARGETING MOLECULES COMPRISING PROTEASE-CLEAVAGE RESISTANT, SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES AND CARBOXY-TERMINAL MOIETIES | Sep 23, 2020 | Abandoned |
Array
(
[id] => 17930109
[patent_doc_number] => 20220325234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => BACTERIAL STRAINS, THEIR COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/761843
[patent_app_country] => US
[patent_app_date] => 2020-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8637
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761843
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/761843 | BACTERIAL STRAINS, THEIR COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS | Sep 20, 2020 | Abandoned |
Array
(
[id] => 18034679
[patent_doc_number] => 20220378894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => PROTEIN PARTICLES COMPRISING A DIPHTHERIA TOXIN CROSS REACTING MATERIAL (CRM) AMINO ACID SEQUENCE AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/761744
[patent_app_country] => US
[patent_app_date] => 2020-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64700
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761744
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/761744 | PROTEIN PARTICLES COMPRISING A DIPHTHERIA TOXIN CROSS REACTING MATERIAL (CRM) AMINO ACID SEQUENCE AND USES THEREOF | Sep 20, 2020 | Abandoned |
Array
(
[id] => 17929824
[patent_doc_number] => 20220324949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => ANTI-ALPHA-HEMOLYSIN ANTIBODY AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/761959
[patent_app_country] => US
[patent_app_date] => 2020-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12413
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761959
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/761959 | ANTI-ALPHA-HEMOLYSIN ANTIBODY AND USE THEREOF | Sep 17, 2020 | Abandoned |
Array
(
[id] => 20607102
[patent_doc_number] => 12582681
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-24
[patent_title] => Fermented milk product for administration in canids such as dogs, and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/642602
[patent_app_country] => US
[patent_app_date] => 2020-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10621
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17642602
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/642602 | Fermented milk product for administration in canids such as dogs, and uses thereof | Sep 10, 2020 | Issued |
Array
(
[id] => 16726421
[patent_doc_number] => 20210093568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => LOADING OF EXTRACELLULAR VESICLES THROUGH IMPARTING OF MECHANICAL SHEAR
[patent_app_type] => utility
[patent_app_number] => 17/014961
[patent_app_country] => US
[patent_app_date] => 2020-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9767
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17014961
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/014961 | LOADING OF EXTRACELLULAR VESICLES THROUGH IMPARTING OF MECHANICAL SHEAR | Sep 7, 2020 | Abandoned |
Array
(
[id] => 17814314
[patent_doc_number] => 11419902
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-23
[patent_title] => Compositions comprising bacterial strains
[patent_app_type] => utility
[patent_app_number] => 17/013026
[patent_app_country] => US
[patent_app_date] => 2020-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 72
[patent_figures_cnt] => 110
[patent_no_of_words] => 45313
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17013026
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/013026 | Compositions comprising bacterial strains | Sep 3, 2020 | Issued |
Array
(
[id] => 18301095
[patent_doc_number] => 11622981
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-11
[patent_title] => Bacterial strain useful for treatment of age-related conditions
[patent_app_type] => utility
[patent_app_number] => 16/947866
[patent_app_country] => US
[patent_app_date] => 2020-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 8
[patent_no_of_words] => 10647
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16947866
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/947866 | Bacterial strain useful for treatment of age-related conditions | Aug 20, 2020 | Issued |